NZ250344A - Zearalenone analogues, their preparation from a fungal fermentation, the fungal strain, and pharmaceutical compositions - Google Patents

Zearalenone analogues, their preparation from a fungal fermentation, the fungal strain, and pharmaceutical compositions

Info

Publication number
NZ250344A
NZ250344A NZ250344A NZ25034493A NZ250344A NZ 250344 A NZ250344 A NZ 250344A NZ 250344 A NZ250344 A NZ 250344A NZ 25034493 A NZ25034493 A NZ 25034493A NZ 250344 A NZ250344 A NZ 250344A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
trans
cis
choh
Prior art date
Application number
NZ250344A
Other languages
English (en)
Inventor
Michael Morris Dreyfuss
Albert Leutwiler
Andrew Roland Mackenzie
Jorg Schnyder
Rene Paul Traber
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ250344A publication Critical patent/NZ250344A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
NZ250344A 1992-12-04 1993-12-02 Zearalenone analogues, their preparation from a fungal fermentation, the fungal strain, and pharmaceutical compositions NZ250344A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929225396A GB9225396D0 (en) 1992-12-04 1992-12-04 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
NZ250344A true NZ250344A (en) 1995-10-26

Family

ID=10726140

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ250344A NZ250344A (en) 1992-12-04 1993-12-02 Zearalenone analogues, their preparation from a fungal fermentation, the fungal strain, and pharmaceutical compositions

Country Status (18)

Country Link
EP (1) EP0606044A1 (OSRAM)
JP (1) JPH06228122A (OSRAM)
KR (1) KR940014377A (OSRAM)
CN (1) CN1095417A (OSRAM)
AU (1) AU5211293A (OSRAM)
CA (1) CA2110553A1 (OSRAM)
CZ (1) CZ261493A3 (OSRAM)
FI (1) FI935409L (OSRAM)
GB (1) GB9225396D0 (OSRAM)
HU (1) HUT65910A (OSRAM)
IL (1) IL107838A0 (OSRAM)
MX (1) MX9307608A (OSRAM)
NO (1) NO934372L (OSRAM)
NZ (1) NZ250344A (OSRAM)
PL (1) PL301281A1 (OSRAM)
SK (1) SK135493A3 (OSRAM)
TW (1) TW258736B (OSRAM)
ZA (1) ZA939088B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228328C2 (de) * 1992-08-26 1999-02-11 Agie Sa Maschine und Verfahren zum funkenerosiven Drahtschneiden mit einer im Querschnitt verformten Drahtelektrode
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
US5731343A (en) * 1995-02-24 1998-03-24 The Scripps Research Institute Method of use of radicicol for treatment of immunopathological disorders
WO1996033989A1 (fr) * 1995-04-26 1996-10-31 Kyowa Hakko Kogyo Co., Ltd. Derives de radicicol
WO2000038674A1 (en) * 1998-12-24 2000-07-06 Novation Pharmaceuticals Inc. COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
ATE328888T1 (de) 2000-08-25 2006-06-15 Sloan Kettering Inst Cancer Radicicol und monocillin und ihre analogen und ihre anwendungen
JP2004292315A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd Ｔａｋ１阻害剤
JP2004292314A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd ケラチノサイト増殖抑制剤
GB0112522D0 (en) * 2001-05-23 2001-07-11 Ici Plc Catalytic process
US7915306B2 (en) 2002-03-08 2011-03-29 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
CN104876904A (zh) 2002-03-08 2015-09-02 卫材R&D管理株式会社 用作医药品的大环化合物
WO2003086334A1 (fr) * 2002-04-17 2003-10-23 Taisho Pharmaceutical Co., Ltd. Produit tonique pour la pousse de cheveux
US20060079494A1 (en) * 2004-09-27 2006-04-13 Santi Daniel V Specific kinase inhibitors
US7601852B2 (en) 2006-05-11 2009-10-13 Kosan Biosciences Incorporated Macrocyclic kinase inhibitors
US8609640B2 (en) 2007-07-25 2013-12-17 Eisai, Inc. Multikinase inhibitors for use in the treatment of cancer
EP2215471B1 (en) 2007-10-29 2012-02-08 Eisai R&D Management Co., Ltd. Methods for prognosing the ability of a zearalenone analog compound to treat cancer
CN101889005B (zh) 2007-12-07 2015-06-03 卫材R&D管理株式会社 玉米赤霉烯酮大环内酯类似物合成过程中的中间物
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196019A (en) * 1964-04-06 1965-07-20 Purdue Research Foundation Anabolic and estrogenic compound and process of making

Also Published As

Publication number Publication date
JPH06228122A (ja) 1994-08-16
ZA939088B (en) 1995-06-05
FI935409A7 (fi) 1994-06-05
CN1095417A (zh) 1994-11-23
TW258736B (OSRAM) 1995-10-01
FI935409A0 (fi) 1993-12-02
KR940014377A (ko) 1994-07-18
EP0606044A1 (en) 1994-07-13
SK135493A3 (en) 1994-08-10
CZ261493A3 (en) 1994-07-13
CA2110553A1 (en) 1994-06-05
NO934372D0 (no) 1993-12-02
PL301281A1 (en) 1994-06-13
HUT65910A (en) 1994-07-28
GB9225396D0 (en) 1993-01-27
NO934372L (no) 1994-06-06
HU9303444D0 (en) 1994-04-28
AU5211293A (en) 1994-06-16
MX9307608A (es) 1995-01-31
FI935409L (fi) 1994-06-05
IL107838A0 (en) 1994-04-12

Similar Documents

Publication Publication Date Title
NZ250344A (en) Zearalenone analogues, their preparation from a fungal fermentation, the fungal strain, and pharmaceutical compositions
AU640756B2 (en) 2,8-dioxabicyclo(3,2,1)octane derivatives,their production from cultures of MF 5447 and MF 5466 and their use as anti hyper cholesterolemics
EP0099692A1 (en) New furanone derivatives, process for the preparation thereof and use thereof
US5079263A (en) Manumycin derivatives and the use thereof
EP1296989B1 (en) Polycyclic xanthones as antibiotics
US5863773A (en) Antifungal corynecandin
JPH024785A (ja) ストレプトミセス属からの新規なフラン類およびラクトン類
US5712306A (en) Physiologically active substances PF1092A, PF1092B and PF1092C, and contraceptives and anticancer drugs containing the same as active ingredients
AU750509B2 (en) Mumbaistatin, a process for its production and its use as a pharmaceutical
US6784203B1 (en) Cytokine production inhibitors
US3701787A (en) Preparation of 5,6-dihydro-5-hydroxy-6-propenyl-2-pyrone by fermentation and derivatives thereof
IE912713A1 (en) Process for the stereoselective preparation of 5-substituted¹ -lactones and use thereof
US5292898A (en) Process for the stereoselective preparation of 5-substituted delta-lactones and use thereof
FR2579599A1 (fr) Substance physiologiquement active tpi et procede de preparation
JPH05331171A (ja) プソイロチンｆ１／ｆ２、アスペルギルス・フミガタスから得られる新規な代謝産物、その調製方法およびその使用
US4912133A (en) BU-3862T antitumor antibiotic
KR100322240B1 (ko) 페니실리움 속(Ｐｅｎｉｃｉｌｌｉｕｍ ｓｐ.)Ｆ70614(ＫＣＴＣ 8918Ｐ)와 α-글루코시다제 저해제
US5248790A (en) Aminoalkylphosphonic acid esters of natural 4-methoxy-5-methyl-pyran-3-ol and derivatives thereof
KR100427411B1 (ko) 아스퍼질러스 속 Ｆ７０６０９（ＫＣＴＣ１８０５５Ｐ）와 β－글루코시다제 저해제
WO1991008222A1 (fr) Substance physiologiquement active be-16627
US5441987A (en) Antifungal agent
CA2020878C (en) Antitumor antibiotic bu-3285t
US5089522A (en) Antitumor antibiotic BU-3285T
WO2001046451A1 (fr) Migrastatine, procede de production et compositions medicales correspondants
JP4585644B2 (ja) 新規物質ｐｆ１２２３およびその製造法